dr. andreadis on the treatment of relapsed dlbcl
Published 5 years ago • 208 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
0:53
dr. andreadis on treatment approaches in relapsed mcl
-
1:01
dr. andreadis discusses the role of ibrutinib in dlbcl
-
1:31
dr. andreadis on antibody-drug conjugates in dlbcl
-
6:08
relapsed/refractory dlbcl treatment landscape
-
1:41
dr. andreadis on the current state of car t-cell therapy in lymphoma
-
1:11
dr. andreadis on car t-cell therapy in relapsed/refractory mcl
-
1:09
dr. hill on the impact of recent approvals in relapsed/refractory dlbcl
-
1:07
dr. christian gisselbrecht on outcomes of relapsed dlbcl
-
1:55
initial steps for treatment of dlbcl
-
6:05
r/r dlbcl: car t therapy and immune checkpoint inhibition
-
4:10
treating relapsed diffuse large b-cell lymphoma
-
5:44
treatment of newly diagnosed dlbcl
-
3:05
emerging treatments for relapsed/refractory dlbcl
-
1:39
managing early & late relapse after first-line therapy for dlbcl
-
2:25
relapse in dlbcl - addressing the unmet need with brentuximab vedotin
-
6:37
l-mind trial in relapsed/refractory dlbcl
-
1:03
dr. pagel on challenges with asct in relapsed/refractory dlbcl
-
7:46
relapsed/refractory dlbcl
-
1:16
dr. balzarotti on questions with consolidation and maintenance therapy in r/r dlbcl